Zychrome® brand chromium dinicocysteinate is a unique, patent-pending, chromium complex. Preliminary clinical data of a 90-day, randomized, double-blind, placebo-controlled study conducted in the United States suggests that Zychrome® supports normal insulin sensitivity, activity and levels trending toward normal range, compared to baseline.*
Helpful Answers
Zychome® brand chromium dinicocysteinate is a unique, patent-pending, chromium complex. This new form of chromium has been studied in preliminary clinical research to help maintain insulin function and healthy insulin levels trending toward normal range.*
Preliminary clinical research has shown that Zychrome®:
– May help support healthy insulin levels trending toward normal range compared to baseline.*
– May help support normal insulin function trending toward normal range compared to baseline.*
The suggested adult daily use is 400 mcg (elemental chromium as Zychrome®). Consumers interested in supplementing with Zychrome can refer to the manufacturer's suggested use printed on the finished product label and/or talk to their healthcare professional.
Manufacturers interested in using Zychrome in finished product applications, please contact InterHealth at 707-751-2800.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.